Teva Doubles Down On Alvotech Biosimilars Partnership

Invests $40m, Adds Two More Biosimilars To Deal And Actively Supports Quality Efforts

Cogs with Quality and Manufacturing words
Teva will get more actively involved in Alvotech’s quality processes • Source: Shutterstock

More from Deals

More from Business